Sarcoidosis is a well known systemic disorder that invariably involves lungs. However, pulmonary hypertension and cor-pulmanle are not common due to pulmonary involvement of sarcoidosis. We report a case of pulmonary hypertension leading to corpulmonale due to sarcoidosis. An elderly female suffering from hypertension & sarcoidosis developed complications and arrived at the diagnosis by correlating various investigations. X-ray chest (P/A) showed cardiomegaly (right ventricular type), reticulo-nodular shadow involving both mid and lower zone; characteristic high resolution CT (HRCT) scan appearances include reticulonodular opacities; pulmonary function test showed restrictive type of defect; ECG showed right ventricular hypertrophy with strain pattern; in echocardiogram there were right ventricular hypertrophy (RVH) with pulmonary artery systolic pressure (PASP) of 63 mmHg indicating severe pulmonary arterial hypertension (PH); along with significantly elevated B-type natriuretic peptide(BNP) level.
In February, 2015, a 67 years old female got admitted at the hospital with the complaints of progressively increased breathlessness from NYHA class 1-2 for 1 month to NYHA class 3-4 for 7 days prior to admission which made her bed bound. It was associated with orthopnea but there was no history of PND or any exacerbating factors like exposure to dust, mites, pollen or drug. She gave a history that she had been a diagnosed case of sarcoidosis for last 7-8 years, while she experienced mild degree of self limiting shortness of breath. She also noted non productive cough which became severe in the last seven days. On further questioning she also revealed history of gradual weight loss associated with loss of appetite but she denied any H/O chest pain, fever, night sweat or hemoptysis. On examination, She was well oriented, alert, co-operative, intelligent with average body built and good nutritional status but she was mildly anemic, edematous, dypnoeic and was in propped up position. Her JVP was raised to 12 cm of H 2 O at 45 degree angle with prominent a wave. BP was 130/70 mm Hg, pulse was 84 beats/min, regular. Her precordium was bulged; apex beat was felt in 5 th intercostal space 11 cm lateral to midline, lateral to mid clavicular line. There was palpable P2 and left parastenal heave. First heart sound was soft; pulmonary component of the second heart sound was loud. There was a pansystolic, grade 3/6 murmur, soft blowing in nature in left lower parasternal area better audible in breath held in inspiration. Her RR was 30/min, movement of the chest was symmetrically diminished to 4 cm, use of accessory muscles was prominent and there was intercostal and subcostal recession. Vocal fremitus and vocal resonance were increased in mid and lower zone. Percussion note was dull; coarse end inspiratory crepitations were heard (Bangladesh Heart Journal 2015; 30(1) : [37] [38] [39] [40] [41] [42] especially in mid and lower zones of the chest on both sides. There was no organomegaly.
Her baseline investigations showed mild anemia, mild renal impairment, hyperurecemia along with significantly elevated BNP level (10,252 pg/ ml) with hymphopenia (15%). ABG-analysis was normal. Liver function and Thyroid function test were normal. Tuberculin skin test was negative and nucleic acid amplification test for detection of both tubercular DNA and rifampicin resistance was also negative. Lung function test revealed restrictive pattern and 6 minute walk test showed moderate exercise tolerance.
X-ray chest (P/A) showed cardiomegaly (right ventricular type), bilateral bronchovascular accentuation was noted. Right pulmonary artery (PA) was dilated which contrasts with peripheral pruning of blood vessel. Reticulo rodular opacities with honey comb shadows were also seen in both mid and lower zone ( She was treated with furosemide, amlodipine, enoxaparin, bosentan, intravenous methylprednisolone followed by oral prednisolone and methotrexate. She was discharged two weeks after hospitalization and she came for further follow up after one month with significant symptomatic relief. Intensity of tricuspid regurgitation was found only mild to moderate with PASP 45 mm Hg.
Discussion:
Pulmonary hypertension (PH) is a haemodynamic and pathophysiological state that can be found in multiple clinical conditions which have been classified into six diagnostic groups with specific histological, clinical and therapeutic features. [1] [2] [3] Updated clinical classification of pulmonary hypertension 1-3 :
Pulmonary arterial hypertension. Pulmonary veno-occlusive disease.
2.
Pulmonary hypertension due to left heart disease.
3.
Pulmonary hypertension due to lung disease or hypoxia.
4.
Chronic thromboembolic pulmonary hypertension.
5.
Pulmonary hypertension unclear multifactorial mechanisms.
Clinical suspiction of PH should arise in any case of breathlessness without overt signs of specific heart or lung diseases. 
Calcium channel blocker (CCB):
Only about half of IPAH positive acute responders (defined as a reduction of mean PAP >10 mm Hg to reach an absolute value of mean PAP < 40 mm Hg with an increase or unchanged cardiac output, done using short acting pulmonary vasodilator I.V PGI 2, or adenosine & inhaled nitric oxide at the time of right heart catheterization) are also positive long term responders to CCB & only in these case the continuation of CCB as single treatment is warranted. 3, 9 4. Digitalis: Short term I.V administration produces & modest increase in cardiac output & significant reduction of circulating nor-epinephrine levels; however no data are available on the effects of long term treatment. It may be used in the rare PAH patients with atrial fibrillation (AF) or atrial flutter (AFL) to slow ventricular rate. 3 
Synthetic prostacyclin & prostacyclin analogues

